Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia

被引:23
作者
Immerzeel, Jos [1 ]
Israel, Bas [2 ,3 ]
Bomers, Joyce [2 ]
Schoots, Ivo G. [4 ,5 ]
Van Basten, Jean-Paul [6 ,7 ]
Kurth, Karl-Heinz [1 ]
de Reijke, Theo [1 ,8 ]
Sedelaar, Michiel [3 ,7 ]
Debruyne, Frans [1 ]
Barentsz, Jelle [1 ,2 ]
机构
[1] Andros Clin, Dept Urol, Arnhem, Netherlands
[2] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Med Imaging, Med Ctr, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Urol, Med Ctr, Nijmegen, Netherlands
[4] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[5] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands
[6] Canisius Wilhelmina Hosp, Dept Urol, Nijmegen, Netherlands
[7] Prosper Collaborat Prostate Canc Clin, Nijmegen, Netherlands
[8] Univ Amsterdam, Dept Urol, Amsterdam UMC, Amsterdam, Netherlands
关键词
Complications; Local anesthesia; Prostate cancer; Transperineal; Please visit; INFECTIOUS COMPLICATIONS; TARGETED BIOPSY; MRI; PREVENTION;
D O I
10.1016/j.eururo.2021.10.032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Transperineal magnetic resonance imaging-transrectal ultrasound fusion guided biopsy (MFGB) is an increasingly popular technique due to increasing rates of biopsy-related infections. However, its widespread implementation has been hampered by the supposed necessity of epidural or general anesthesia. Objective: To demonstrate the technique, feasibility, and results of transperineal MFGB under local anesthesia, in an ambulatory setting without the administration of prophylactic antibiotics. Design, setting, and participants: This single-center study enrolled consecutive biopsynaive men with a clinical suspicion of prostate cancer into a prospective database between November 2015 and November 2020. Men with Prostate Imaging Reporting and Data System (PI-RADS) version 2 scores 3-5 underwent transperineal MFGB. Surgical procedure: Transperineal MFGB was performed in an ambulatory setting under local anesthesia by a single operator. Measurements: Procedure-associated adverse events were recorded. Patient discomfort during both the local anesthesia and the biopsy procedure was determined using a visual analogic scale (0-10). Detection rates of grade group (GG) >2 prostate cancer and the proportion of men with GG 1 cancer were assessed. Results and limitations: A total of 1097 eligible men underwent transperineal MFGB. The complication rate was 0.73% (8/1097); complications comprised five (0.46%) urinary tract infections including one hospitalization and three (0.27%) urinary retentions. In 735 men, the median pain scores were 2 (interquartile range [IQR] 2-3) for the local anesthesia procedure and 1 (IQR 0-2) for the biopsy. Prostate cancer was detected in 84% (926/1097) of men; 66% (723/1097) had GG >2 and 19% (203/1097) GG 1. Conclusions: Transperineal MFGB can safely be performed as an outpatient proce- dure under local anesthesia in an ambulatory setting. The detection rate of clinically significant prostate cancer is high, and biopsy is well tolerated. Although no antibi- otic prophylaxis was used, the rate of infectious complications is practicably negligible. Patient summary: This article shows how tissue samples (biopsies) can accurately be obtained from suspicious regions seen on prostate magnetic resonance imaging via nee- dles inserted in the perineum (skin between the scrotum and the anus) in men with sus- pected prostate cancer. This technique appears to be very well tolerated under local anesthesia and has a lower risk of infection without antibiotic prophylaxis than the more common biopsy route through the rectum, with antibiotics. (c) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
引用
收藏
页码:110 / 117
页数:8
相关论文
共 40 条
[1]   Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study [J].
Ahmed, Hashim U. ;
Bosaily, Ahmed El-Shater ;
Brown, Louise C. ;
Gabe, Rhian ;
Kaplan, Richard ;
Parmar, Mahesh K. ;
Collaco-Moraes, Yolanda ;
Ward, Katie ;
Hindley, Richard G. ;
Freeman, Alex ;
Kirkham, Alex P. ;
Oldroyd, Robert ;
Parker, Chris ;
Emberton, Mark .
LANCET, 2017, 389 (10071) :815-822
[2]   Guidelines for Reporting of Statistics for Clinical Research in Urology [J].
Assel, Melissa ;
Sjoberg, Daniel ;
Elders, Andrew ;
Wang, Xuemei ;
Huo, Dezheng ;
Botchway, Albert ;
Delfino, Kristin ;
Fan, Yunhua ;
Zhao, Zhiguo ;
Koyama, Tatsuki ;
Hollenbeck, Brent ;
Qin, Rui ;
Zahnd, Whitney ;
Zabor, Emily C. ;
Kattan, Michael W. ;
Vickers, Andrew J. .
EUROPEAN UROLOGY, 2019, 75 (03) :358-367
[3]   Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach [J].
Bass, E. J. ;
Donaldson, I. A. ;
Freeman, A. ;
Jameson, C. ;
Punwani, S. ;
Moore, C. ;
Arya, M. ;
Emberton, M. ;
Ahmed, H. U. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) :311-317
[4]   Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer [J].
Bjurlin, Marc A. ;
Carroll, Peter R. ;
Eggener, Scott ;
Fulgham, Pat F. ;
Margolis, Daniel J. ;
Pinto, Peter A. ;
Rosenkrantz, Andrew B. ;
Rubenstein, Jonathan N. ;
Rukstalis, Daniel B. ;
Taneja, Samir S. ;
Turkbey, Baris .
JOURNAL OF UROLOGY, 2020, 203 (04) :706-712
[5]   Time to Adapt Our Practice? The European Commission Has Restricted the Use of Fluoroquinolones since March 2019 [J].
Bonkat, Gernot ;
Pilatz, Adrian ;
Wagenlehner, Florian .
EUROPEAN UROLOGY, 2019, 76 (03) :273-275
[6]   Increasing Risk of Infectious Complications After Transrectal Ultrasound-Guided Prostate Biopsies: Time to Reassess Antimicrobial Prophylaxis? [J].
Carignan, Alex ;
Roussy, Jean-Francois ;
Lapointe, Veronique ;
Valiquette, Louis ;
Sabbagh, Robert ;
Pepin, Jacques .
EUROPEAN UROLOGY, 2012, 62 (03) :453-459
[7]   Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis [J].
Drost, Frank-Jan H. ;
Osses, Daniel ;
Nieboer, Daan ;
Bangma, Chris H. ;
Steyerberg, Ewout W. ;
Roobol, Monique J. ;
Schoots, Ivo G. .
EUROPEAN UROLOGY, 2020, 77 (01) :78-94
[8]   Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition [J].
Engels, Rianne R. M. ;
Israel, Bas ;
Padhani, Anwar R. ;
Barentsz, Jelle O. .
EUROPEAN UROLOGY, 2020, 77 (04) :457-468
[9]   The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System [J].
Epstein, Jonathan I. ;
Egevad, Lars ;
Amin, Mahul B. ;
Delahunt, Brett ;
Srigley, John R. ;
Humphrey, Peter A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) :244-252
[10]  
Food and Drug Administration, DRUG SAF COMM FDA UP